Table 1

Summary of mutation analysis assays

GeneType*MutationAssayReferences
FLT3 Type I ITD Fragment analysis Cloos, 200630  
  D835 Lightcycler/sequencing Cloos, 200630  
N-RAS/K-RAS Type I Codon 12/13 Lightcycler/sequencing Goemans, 200535 ; Kramer, 200936  
  Codon 61 Lightcycler/sequencing Goemans, 200535  
KIT Type I D816V Lightcycler/sequencing Goemans, 200535  
  Exon 11 ITD Fragment analysis Corbacioglu, 200637  
WT1 No consensus Exon 1, 2, 7, 8, 9, 10 dHPLC, sequencing Hollink, 2009 
CEBPA Type II All coding regions dHPLC, sequencing Wouters, 200938 ; Hollink, 200939  
PTPN11 Type I Exon 3/13 Sequencing Goemans, 200540  
NPM1 No consensus Exon 12 Fragment analysis See “Methods” 
GeneType*MutationAssayReferences
FLT3 Type I ITD Fragment analysis Cloos, 200630  
  D835 Lightcycler/sequencing Cloos, 200630  
N-RAS/K-RAS Type I Codon 12/13 Lightcycler/sequencing Goemans, 200535 ; Kramer, 200936  
  Codon 61 Lightcycler/sequencing Goemans, 200535  
KIT Type I D816V Lightcycler/sequencing Goemans, 200535  
  Exon 11 ITD Fragment analysis Corbacioglu, 200637  
WT1 No consensus Exon 1, 2, 7, 8, 9, 10 dHPLC, sequencing Hollink, 2009 
CEBPA Type II All coding regions dHPLC, sequencing Wouters, 200938 ; Hollink, 200939  
PTPN11 Type I Exon 3/13 Sequencing Goemans, 200540  
NPM1 No consensus Exon 12 Fragment analysis See “Methods” 

ITD indicates internal tandem duplication; dHPLC, denaturing high-performance liquid chromatography.

*

Specifies to which category a mutation for the given gene belongs according to the “2-hit model” by Gilliland et al.12  When consensus is lacking in the literature as to which category a mutation belongs, it is so stated.

or Create an Account

Close Modal
Close Modal